Banner

News

Article

SHL Medical opens state-of-the-art manufacturing facility in South Carolina

Author(s):

Key Takeaways

  • SHL Medical's new facility in South Carolina strengthens its U.S. market presence and production capacity for autoinjectors, especially in cardiometabolic treatments.
  • The $220 million investment in a 360,000-square-foot facility supports high precision and efficiency with cutting-edge technology.
SHOW MORE

Swiss-based company’s plant will increase capacity to meet demand for autoinjectors

VIPs touring SHL Medical's new South Carolina plant: ©SHL Medical

VIPs touring SHL Medical's new South Carolina plant: ©SHL Medical

SHL Medical, a manufacturer of self-injection solutions, has opened a new manufacturing facility in North Charleston, South Carolina. The Swiss-based company’s expansion strengthens its presence in the U.S. market and boosts its production capacity to meet the growing demand for autoinjectors, particularly in the cardiometabolic sector.

The new 360,000-square-foot facility, representing a $220 million investment, is designed to manufacture SHL Medical’s autoinjectors used in the treatment of endocrine and metabolic disorders—including GLP-1 therapies—as well as dermatology, musculoskeletal diseases, and other therapeutic areas.

“U.S.-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions,” said Ulrich Faessler, CEO & chairman of SHL Medical. “With our established site in Taiwan and the upcoming facility in Switzerland, we will be the only autoinjector manufacturer operating across three continents, bringing us even closer to our customers.”

Equipped with cutting-edge injection molding technology and fully automated assembly capabilities, the facility ensures high precision, efficiency, and quality in drug delivery solutions. The site has already created over 300 local jobs, contributing to economic growth in the region, according to the company.

By integrating with its existing final assembly, labeling, and packaging operations in Deerfield Beach, Florida, and leveraging recent acquisitions under SHL Advantec, the North Charleston facility enhances the company’s U.S. presence. SHL Medical is on track to deliver 1.5 billion devices to customers in 2025.

"The most trusted autoinjector brand is now made in the USA. We are proud to be contributing to the growth of the local economy and becoming a key player in the area while contributing to our sustainability goals,” said Kimberlee Steele, Managing Director North America at SHL Medical.

The grand opening event was attended by approximately 180 guests, including South Carolina Governor Henry McMaster and Swiss Embassy Consul General Urs Broennimann.

Related Videos